ACTICOR BIOTECH - 1H - Technical analysis published on 05/07/2024 (GMT)
- 140
- 0
- Timeframe : 1H
- - Analysis generated on
- Status : NEUTRAL
Analysis too old. There are no more charts available.
Summary of the analysis
Trends
Short term:
Bullish
Underlying:
Slightly bearish
Technical indicators
67%
0%
33%
My opinion
Neutral between 0.464 EUR and 0.543 EUR
My targets
-
My analysis
The short-term increase on ACTICOR BIOTECH remains moderate but could challenge the slightly bearish basic trend. It is difficult to advise a trading direction under these conditions. The first resistance is located at 0.543 EUR. The first support is located at 0.464 EUR. You could remain on the sidelines waiting for a more pronounced price movement on this instrument. A new analysis could then be carried out to provide clearer signals.
In the very short term, technical indicators are bullish and could soon allow change to a bullish sentiment.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Londinia. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The ACTICOR BIOTECH price is 0.480 EUR. The price registered an increase of +18.81% on the session and was traded between 0.405 EUR and 0.480 EUR over the period. The price is currently at +18.52% from its lowest and 0% from its highest.0.405
0.480
0.480
The Central Gaps scanner detects a bullish opening marking the presence of buyers ahead of sellers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
A technical analysis in 1H of this ACTICOR BIOTECH chart shows a slightly bearish trend. 57.14% of the signals given by moving averages are bearish. Caution: the slightly bullish signals currently being given by short-term moving averages indicate that this overall trend could be reversed. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, according to the parameters integrated into the Central Analyzer system, 12 technical indicators out of 18 analysed are currently bullish. Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : 1 hour
RSI indicator is back over 50
Type : Bullish
Timeframe : 1 hour
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S1
R1
R2
R3
Price
| S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|
| ProTrendLines | 0.270 | 0.480 | 2.730 | 3.364 | 4.179 |
| Change (%) | -43.75% | - | +468.75% | +600.83% | +770.63% |
| Change | -0.210 | - | +2.250 | +2.884 | +3.699 |
| Level | Major | - | Intermediate | Intermediate | Major |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.335 | 0.358 | 0.381 | 0.404 | 0.427 | 0.450 | 0.473 |
| Camarilla | 0.391 | 0.396 | 0.400 | 0.404 | 0.408 | 0.412 | 0.417 |
| Woodie | 0.335 | 0.358 | 0.381 | 0.404 | 0.427 | 0.450 | 0.473 |
| Fibonacci | 0.358 | 0.376 | 0.386 | 0.404 | 0.422 | 0.432 | 0.450 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.178 | 0.257 | 0.321 | 0.400 | 0.464 | 0.543 | 0.607 |
| Camarilla | 0.345 | 0.358 | 0.371 | 0.384 | 0.397 | 0.410 | 0.423 |
| Woodie | 0.170 | 0.253 | 0.313 | 0.396 | 0.456 | 0.539 | 0.599 |
| Fibonacci | 0.257 | 0.312 | 0.346 | 0.400 | 0.455 | 0.489 | 0.543 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | -4.903 | -2.317 | -0.963 | 1.623 | 2.977 | 5.563 | 6.917 |
| Camarilla | -0.694 | -0.332 | 0.029 | 0.390 | 0.751 | 1.112 | 1.474 |
| Woodie | -5.520 | -2.625 | -1.580 | 1.315 | 2.360 | 5.255 | 6.300 |
| Fibonacci | -2.317 | -0.812 | 0.118 | 1.623 | 3.128 | 4.058 | 5.563 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 54.40 | |
| MACD (12,26,9): | -0.0260 | |
| Directional Movement: | 8.769 | |
| AROON (14): | 100.000 | |
| DEMA (21): | 0.372 | |
| Parabolic SAR (0,02-0,02-0,2): | 0.659 | |
| Elder Ray (13): | 0.036 | |
| Super Trend (3,10): | 0.399 | |
| Zig ZAG (10): | 0.480 | |
| VORTEX (21): | 1.0900 | |
| Stochastique (14,3,5): | 90.34 | |
| TEMA (21): | 0.507 | |
| Williams %R (14): | 0.00 | |
| Chande Momentum Oscillator (20): | 0.090 | |
| Repulse (5,40,3): | 11.2900 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | -1.0060 | |
| Courbe Coppock: | 21.36 |
| MA7: | 0.396 | |
| MA20: | 2.415 | |
| MA50: | 3.366 | |
| MA100: | 3.480 | |
| MAexp7: | 0.436 | |
| MAexp20: | 0.426 | |
| MAexp50: | 0.745 | |
| MAexp100: | 1.450 | |
| Price / MA7: | +21.21% | |
| Price / MA20: | -80.12% | |
| Price / MA50: | -85.74% | |
| Price / MA100: | -86.21% | |
| Price / MAexp7: | +10.09% | |
| Price / MAexp20: | +12.68% | |
| Price / MAexp50: | -35.57% | |
| Price / MAexp100: | -66.90% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
The latest news and videos published on ACTICOR BIOTECH at the time of the analysis were as follows:
- The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, first clinical trial evaluating glenzocimab for heart attack
- Acticor Biotech has just and timely completed patient recruitment of its phase 2/3 study in stroke
- Acticor adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatment of stroke
- ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of July 31, 2023
- Acticor Biotech: Half-Year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis ACTICOR BIOTECH - 1H